Susceptibility of Diabetic Heart to Catecholamine-induced Arrhythmias is Independent of Contractile Dysfunction

1. Dhalla NS, Adameova A, Kaur M. Role of catecholamine oxidation in sudden cardiac death. Fund Clin Pharmacol 2010; 24: 539-46.10.1111/j.1472-8206.2010.00836.x20584205Search in Google Scholar

2. Sethi R, Rehsia NS, Jindal K, et al. Antiarrhythmic effects of some antioxidant vitamins in rats injected with epinephrine. Cardiovasc Toxicol 2009 9: 177-84.10.1007/s12012-009-9051-519763903Search in Google Scholar

3. Sethi R, Adameova A, Dhalla KS, et al. Modification of epinephrine-induced arrhythmias by N-acetyl-Lcysteine and vitamin E. J Cardiovasc Pharmacol Ther 2009; 14:134-42.10.1177/107424840933385519339682Search in Google Scholar

4. Adameova A, Abdellatif Y, Dhalla NS. Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease. Can J Physiol Pharmacol 2009; 8: 493-514.10.1139/Y09-04219767873Search in Google Scholar

5. Goyal BR, Mesariya P, Goyal RK, Mehta AA. Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats. Mol Cell Biochem 2008: 314: 123-31.10.1007/s11010-008-9772-y18425420Search in Google Scholar

6. Malone MA, Schocken DD, Hanna SK, Liang X, Malone JI. Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine. Metabolism 2007; 56: 1118-23.10.1016/j.metabol.2007.04.00517618959Search in Google Scholar

7. Nobe S, Aomine M, Arita M, Ito S, Takaki R. Chronic diabetes mellitus prolongs action potential duration of rat ventricular muscles: circumstantial evidence for impaired Ca2+ channel. Cardiovasc Res 1990; 24: 381-9.10.1093/cvr/24.5.3812164883Search in Google Scholar

8. Casis O, Gallego M, Iriarte M, Sanchez-Chapula A. Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle. Diabetologia 2000; 43: 101-9.10.1007/s00125005001310672450Search in Google Scholar

9. Shimoni Y, Chen K, Emmett T, Kargacin G. Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart. Br J Pharmacol 2008; 154: 675-87.10.1038/bjp.2008.114243952818414392Search in Google Scholar

10. Jourdon P, Feuvray D. Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J Physiol 1993; 470: 411-29.10.1113/jphysiol.1993.sp01986611439258308734Search in Google Scholar

11. Fein FS. Diabetic cardiomyopathy. Diabetes Care 1990; 13: 1169-79.10.2337/diacare.13.11.11692261838Search in Google Scholar

12. Regan TJ, Ahmed S, Haidar B, Moschos C, Weisse A.Diabetic cardiomyopathy: Experimental and clinical observations. New Engl J Med 1994; 91: 776-8.Search in Google Scholar

13. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 1983; 244: E528-35.10.1152/ajpendo.1983.244.6.E5286134470Search in Google Scholar

14. Rees SA, Curtis MJ. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate. Circulation 1993; 87: 1979- 1789.10.1161/01.CIR.87.6.19798504513Search in Google Scholar

15. Barta J, Sanganalmath SK, Kumamoto H, Takeda N, Edes I, Dhalla NS. Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality. Cardiovasc Toxicol 2008; 8: 127-35.10.1007/s12012-008-9019-x18751928Search in Google Scholar

16. Walker MJ, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction and reperfusion. Cardiovasc Res 1988; 22: 447-55.10.1093/cvr/22.7.4473252968Search in Google Scholar

17. Sanganalmath SK, Babick AP, Barta J, Kumamoto H, Takeda N, Dhalla NS. Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure. J Cell Mol Med 2008; 12: 1728-38.10.1111/j.1582-4934.2007.00197.x391808918088389Search in Google Scholar

18. Vasanji Z, Dhalla NS, Netticadan T. Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart. Mol Cell Biochem 2004; 261: 245-9.10.1023/B:MCBI.0000028762.97754.26Search in Google Scholar

19. Machackova J, Liu X, Lukas A, Dhalla NS. Reninangiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes. Mol Cell Biochem 2004; 261: 271-8.10.1023/B:MCBI.0000028765.89855.73Search in Google Scholar

20. Tappia PS, Asemu G, Aroutiounova N, Dhalla NS.Defective sarcolemmal phospholipase C signaling in diabetic cardiomyopathy. Mol Cell Biochem 2004; 261: 193-9.10.1023/B:MCBI.0000028756.31782.46Search in Google Scholar

21. Sauviat MP, Feuvray D. Electrophysiological analysis of the sensitivity to calcium in ventricular muscle from alloxan diabetic rats. Basic Res Cardiol 1986; 81: 489-96.10.1007/BF019077553800847Search in Google Scholar

22. Howarth FC, Jacobson M, Shafiullah M, Adeghate E. Long-term effects of streptozotocin- induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Physiology 2005; 90: 827-35.Search in Google Scholar

23. Rana BS, Band MM, Ogston S, Morris AD, Pringle SD, Struthers AD. Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol 2002; 90: 483-7.10.1016/S0002-9149(02)02518-3Search in Google Scholar

24. Takebayashi K, Sugita R, Tayama K, Aso Y, Takemura Y, Inukai T. The connection between QT dispersion and autonomic neuropathy in patients with type 2 diabetes.Exp Clin Endocrinol Diabetes 2003; 111: 351-7.10.1055/s-2003-42726Search in Google Scholar

25. Dhalla NS, Liu X, Panagia V, Takeda N. Subcellular remodeling and heart dysfunction in chronic diabetes.Cardiovasc Res 1998; 40: 239-47.10.1016/S0008-6363(98)00186-2Search in Google Scholar

26. Dhalla NS, Takeda N, Rodriquez-Leyva D, Elimban V.Mechanisms of subcellular remodeling in heart failure due to diabetes. Heart Fail Rev 2014; 19: 87-99.10.1007/s10741-013-9385-8Search in Google Scholar

27. Marfella R, Rossi F, Giugliano D. Hyperglycemia and QT interval: time for re-evaluation. Diabetes Nutr Metab 2011; 14: 63-5.Search in Google Scholar

28. Christensen NJ. Plasma catecholamines in long-term diabetics with and without neuropathy and in hypophysectomized subjects. J Clin Invest 1972; 51: 779-87.10.1172/JCI106872Search in Google Scholar

29. Porojan M, Costin M, Poantă L, et al. Autonomic neuropathy and plasma catecholamine in patients with diabetes mellitus. Rom J Intern Med 2010; 48: 341-5.Search in Google Scholar

30. Heyman E, Delamarche P, Berthon P, et al. Alteration in sympathoadrenergic activity at rest and during intense exercise despite normal aerobic fitness in late pubertal adolescent girls with type 1 diabetes. Diabetes Metab 2007; 33: 422-9.10.1016/j.diabet.2007.10.003Search in Google Scholar

31. Kondo K, Matsubara T, Nakamura J, Hotta N. Characteristic patterns of circadian variation in plasma catecholamine levels, blood pressure and heart rate variability in Type 2 diabetic patients. Diabet Med 2002; 19: 359-65.10.1046/j.1464-5491.2002.00720.xSearch in Google Scholar

32. Tosaki A, Engelman DT, Engelman RM, Das DK. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts.Cardiovasc Res 1996; 31: 526-36.10.1016/S0008-6363(95)00217-0Search in Google Scholar

33. Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased.Cardiovasc Res 1997; 34: 113-20.10.1016/S0008-6363(97)00037-0Search in Google Scholar

34. Adameova A, Kuzelova M, Andelova E, et al. Hypercholesterolemia abrogates an increased resistance of diabetic rat hearts to ischemia-reperfusion injury. Mol Cell Biochem 2007; 295: 129-36.10.1007/s11010-006-9282-816900395Search in Google Scholar

35. Ravingerova T, Adameova A, Matejikova J, et al.. Subcellular mechanisms of adaptation in the diabetic myocardium: Relevance to ischemic preconditioning in the nondiseased heart. Exp Clin Cardiol 2010; 15: 68-76.Search in Google Scholar

36. Erickson JR, Pereira L, Wang L, et al. Diabetic hyperglycemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 2013; 502: 372-6.10.1038/nature12537380122724077098Search in Google Scholar

37. Netticadan T, Temsah RM, Kent A, Elimban V, Dhalla NS. Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes 2001; 50: 2133-8.10.2337/diabetes.50.9.213311522681Search in Google Scholar

38. Vasanji Z, Cantor EJ, Juric D, Moyen M, Netticadan T. Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance. Am J Physiol Cell Physiol 2006; 291: C772-80.10.1152/ajpcell.00086.200516973823Search in Google Scholar

39. Anderson ME, Brown JH, Bers DM. CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 2011; 51:468-73.10.1016/j.yjmcc.2011.01.012315828821276796Search in Google Scholar

40. Netticadan T, Temsah RM, Kawabata K, Dhalla NS.Sarcoplasmic reticulum Ca2+/Calmodulin-dependent protein kinase is altered in heart failure. Circ Res 2000; 86: 596-60510.1161/01.RES.86.5.59610720422Search in Google Scholar

41. Bhagat BD, Rao PS, Dhalla NS. Role of catecholamines in the genesis of arrhythmias. Adv Myocardial 1980; 2: 117-32.Search in Google Scholar

42. Xu YJ, Tappia PS, Neki NS, Dhalla NS. Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants. Heart Fail Rev 2014; 19:113-21.10.1007/s10741-013-9379-623436032Search in Google Scholar

43. Dincer UD, Bidasee KR, Guner S, Tay A, Ozcelikay T, Altan MV. The effect of diabetes on expression of β1-, β2-, and β3-adrenoreceptors in rats hearts. Diabetes 2001; 50: 455-61.10.2337/diabetes.50.2.45511272160Search in Google Scholar

44. Op den Buijs J, Miklos Z, Van Riel NAW, et al. β-adrenergic activation reveals impaired cardiac calcium handling at early stage of diabetes. Life Sci 2005; 76: 1083-98.10.1016/j.lfs.2004.08.01815620573Search in Google Scholar

45. Woodcock EA, Arthur JF, Matkovich SJ. Inositiol 1,4,5- trisphosphate and reperfusion arrhythmias. Clin Exp Pharmacol Physiol 2000; 27:734-7.10.1046/j.1440-1681.2000.03328.x10972542Search in Google Scholar

46. Tanaka Y, Kashiwagi A, Saeki Y, Shigeta Y. Abnormalities in cardiac α1-adrenoceptor and its signal transduction in streptozotocin-induced diabetic rats. Am J Physiol 1992; 263: E425-9.10.1152/ajpendo.1992.263.3.E4251329523Search in Google Scholar

47. Tanaka Y, Kashiwagi A, Saeki Y, et al. Effects of verapamil on the cardiac α1-adrenoceptor signaling system in diabetic rats. Eur J Pharmacol 1993; 244: 105-9.10.1016/0922-4106(93)90014-ZSearch in Google Scholar

48. Ziegelhoffer A, Bundgaard H, Ravingerova, et al. Diabetes - and semi-starvation-induced changes in metabolism and regulation of Na, K-ATPase in rat heart.Diabetes Nutr Metab 2003; 16: 222-31. Search in Google Scholar